{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-040453","form_type":"8-K","ticker":"LUDG","cik":"0001960262","company_name":"LUDWIG ENTERPRISES, INC.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.576662+00:00","generated_at":"2026-05-22T09:22:05.522981+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"medium","headline":"Ludwig previews Revealia Breast™ cheek-swab test; Q3 2025 launch expected","bullets":["Revealia Breast™ uses mRNA biomarkers and AI from a cheek swab for early cancer detection.","Test is in advanced development with expected release in Q3 2025.","Cites ASBS study: 39.7% non-invasive disease vs 13.2% with traditional management.","First in pipeline of non-invasive mRNA-based cancer screening tests targeting major cancers.","No financial data or revenue projections provided in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-040453","json":"https://secwatch.observer/filing/0001213900-25-040453.json","markdown":"https://secwatch.observer/filing/0001213900-25-040453.md","text":"https://secwatch.observer/filing/0001213900-25-040453.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1960262/000121390025040453/0001213900-25-040453-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1960262/000121390025040453/ea0240968-8k_ludwig.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T09:22:05.522981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}